Cargando…
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma
INTRODUCTION: In clear cell renal cell carcinoma (ccRCC), tumor-associated macrophage (TAM) induction of CD8+T cells into a terminally exhausted state has been implicated as a major mechanism of immunotherapy resistance, but a deeper biological understanding is necessary. METHODS: Primary ccRCC tumo...
Autores principales: | Chakiryan, Nicholas H, Kim, Youngchul, Berglund, Anders, Chang, Andrew, Kimmel, Gregory J, Hajiran, Ali, Nguyen, Jonathan, Moran-Segura, Carlos, Saeed-Vafa, Daryoush, Katende, Esther N, Lopez-Blanco, Neale, Chahoud, Jad, Rappold, Phillip, Spiess, Philippe E, Fournier, Michelle, Jeong, Daniel, Wang, Liang, Teer, Jamie K, Dhillon, Jasreman, Kuo, Fengshen, Hakimi, Abraham Ari, Altrock, Philipp M, Mulé, James J, Manley, Brandon J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151991/ https://www.ncbi.nlm.nih.gov/pubmed/37185232 http://dx.doi.org/10.1136/jitc-2022-006195 |
Ejemplares similares
-
Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2021) -
Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2021) -
Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Ferrall-Fairbanks, Meghan C., et al.
Publicado: (2022) -
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
por: Adashek, Jacob J., et al.
Publicado: (2021) -
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2021)